The increased levels of IL-6 and Intercellular Adhesion Molecule 1 (ICAM-1) have been proposed to be the mediators between poor sleep quality and the development of cardiovascular complications in type 2 diabetic patients [172]. This evidence concerns the gene ICAM1 and type 2 diabetes mellitus.